November 12, 2014 / 3:58 PM / 3 years ago

BUZZ-Allergan Inc: In talks with Actavis - Bloomberg

** Botox-maker’s shares up 1.06 pct at $197.43; Actavis Plc shares down 1.16 pct at $240.79

** Actavis in talks to buy Allergan for at least $60 bln, Bloomberg reports, citing sources

** Deal could culminate this month, Bloomberg reports (bloom.bg/1ubCVL6)

** Allergan, which has a market value of about $58 billion, is currently fending off a hostile takeover from Canadian drugmaker Valeant Pharmaceuticals Inc and activist investor William Ackman’s Pershing Square Capital Management

** Up to Tuesday’s close, Allergan’s shares up about 38 pct since April 21, when Valeant first made its bid

** U.S.-listed shares of Valeant marginally up at $130.21

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below